Phenotypic and target-based approach to antitubercular drug discovery : investigation of thienopyrimidine and hydantoin scaffolds as new hits against Mycobacterium tuberculosis
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences,iii, 334 p.
Selective and orally bioavailable dipeptidyl peptidase 9 inhibitors with potent pyroptosis induction properties
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:21 (2025) p. 23163-23184
Structure-property investigation of new "KetoFAPI" inhibitors of fibroblast activation protein (FAP) : discovery of highly potent, selective compounds with prolonged residence times and promising radiotheranostic potential
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:20 (2025) p. 21739-21765
Biarylacetamides : a novel class of late-stage autophagy inhibitors
Source
Autophagy reports - ISSN 2769-4127-4:1 (2025) p. 1-23
Synthesis and preclinical evaluation of druglike ¹⁸F-labeled fibroblast activation protein (FAP) inhibitors with enhanced tumor retention
Source
Bioconjugate chemistry - ISSN 1043-1802-36:8 (2025) p. 1887-1906